Navicon`s client


NovaMedica is a Russian pharmaceutical company established in 2012 by Domain Associates LLC, a leading U.S. venture capital firm, and RUSNANO, JSC. NovaMedica owns intellectual property rights within Russia and the CIS for 36 innovations which are part of the portfolio of RusnanoMedInvest, and develops a pipeline of its own drug products. In April 2017, the company launched the Technology Center with state-of-the-art technological capabilities which were previously unobtainable in the Russian pharmaceutical industry.

Joint projects

Field sales monitoring
Automate the field sales